A Journal That Punches Above Its Weight
ACS Medicinal Chemistry Letters isn’t the flashiest journal in the ACS family. It doesn’t have the prestige of Journal of the American Chemical Society* or the broad reach of Nature Chemistry*. But here’s what it does have: a solid impact factor that consistently lands in the upper tier of medicinal chemistry journals.
If you’re a researcher, grad student, or industry scientist trying to figure out where to publish your next breakthrough — or just curious why this journal keeps showing up in conversations — this one’s for you.
What Is ACS Medicinal Chemistry Letters?
ACS Medicinal Chemistry Letters is a monthly, peer-reviewed journal published by the American Chemical Society. Launched in 2009, it’s specifically focused on the design, synthesis, and biological evaluation of small molecules with therapeutic potential.
Unlike its bigger sibling, Journal of Medicinal Chemistry*, which publishes comprehensive studies with extensive mechanistic details and large-scale biological testing, ACS Medicinal Letters favors shorter, high-impact communications. Think: novel scaffolds, unexpected SAR trends, or clever synthetic routes that could change how people approach a target.
The journal covers everything from hit identification to lead optimization, but it leans heavily into the early-to-mid stages of drug discovery. On top of that, computational chemistry, structure-based drug design, and fragment-based approaches are all fair game. It’s the kind of journal where you’ll find a new kinase inhibitor series one month and a novel antibiotic scaffold the next.
Who Reads It?
Academic medicinal chemists, pharmaceutical industry researchers, and computational chemists who want to stay current on emerging trends. If you’re working in drug discovery and you’re not at least skimming this journal, you’re missing some genuinely interesting work.
Why It Matters: The Impact Factor Reality
Let’s talk about the elephant in the room. The impact factor.
ACS Medicinal Chemistry Letters’ 2022 impact factor was around 5.7, which puts it solidly in the top 20% of chemistry journals. Which means that’s not Nature*-level, but for a specialized medicinal chemistry journal, it’s respectable. More importantly, it’s been trending upward over the past decade.
Why does this matter? Day to day, because for early-career researchers, choosing where to publish can feel like navigating a minefield. You want visibility, but you also want speed. You want rigor, but you don’t want to wait two years for a decision. ACS Medicinal Letters offers a sweet spot: relatively quick turnaround, solid visibility, and a reputation for publishing work that actually moves projects forward.
The Publishing Strategy Angle
For PhD students and postdocs, publishing in a journal with a strong impact factor in your field can make a real difference in job applications and grant funding. ACS Medicinal Letters sits at that Goldilocks zone — high enough to impress hiring committees, but not so high that you need to have solved a Nobel-worthy problem to get in.
How the Impact Factor Works (And Why It’s Not Everything)
Here’s the thing about impact factors — they’re a blunt instrument. The calculation is simple: take the total number of citations in a given year to articles published in the previous two years, divide by the total number of articles published in those two years. That’s it.
So if ACS Medicinal Chemistry Letters published 500 papers in 2020 and 2021, and those papers were cited 2,850 times in 2022, the 2022 impact factor would be 5.7.
But here’s what most people miss: impact factor doesn’t tell you whether your individual paper will get cited. On the flip side, it doesn’t tell you if the journal is a good fit for your work. And it definitely doesn’t tell you if the editorial board is responsive or if the peer review is fair.
The Real-World Impact
What the impact factor does tell you is that, on average, papers published in this journal are getting noticed. In medicinal chemistry, that means your work is reaching the right audience — people who are actively designing drugs, not just reading about them.
This matters because drug discovery is a collaborative field. Practically speaking, your novel compound might inspire someone else’s project. Consider this: your synthetic route might save someone weeks of failed experiments. The impact factor is a proxy for that kind of influence.
How to Get Published in ACS Medicinal Chemistry Letters
Getting into this journal isn’t easy, but it’s not impossible. Here’s what actually works:
Know Your Story
ACS Medicinal Letters wants concise, compelling narratives. Plus, don’t pad your introduction with 20 references. Tell us why your molecule matters in three paragraphs. Plus, be specific. Be bold.
Hit the Right Length
The journal has strict limits on article length. Letters are typically capped at 4,000 words and four figures. If your story needs more space, consider Journal of Medicinal Chemistry* instead.
Choose Your Co-authors Wisely
ACS journals are strict about authorship. And make sure everyone on your author list contributed meaningfully. And if you’re collaborating with industry, disclose it properly. Nothing kills a submission faster than an ethics flag.
Submit Clean, Polished Work
This isn’t the journal for preliminary data or half-baked ideas. Your synthesis should be solid, your biological data should be reproducible, and your claims should be backed by evidence. If you’re not sure, get a colleague to review your draft before submitting.
Common Mistakes People Make
Honestly, this is the part most guides get wrong.
If you found this helpful, you might also enjoy which of the following describes the process of melting or what glow sticks are made of.
Mistake #1: Submitting Without Reading the Journal
I see this all the time. Researchers write a perfectly good paper, then submit it to ACS Medicinal Letters without ever reading a single issue. Consider this: big mistake. The journal has a distinct voice and style. If your paper doesn’t match that tone, it’s going to get desk-rejected.
Mistake #2: Overstating the Impact
Saying your compound “could lead to new treatments for cancer” when you’ve only tested it in cell culture is a red flag. On top of that, be honest about your limitations. ACS Medicinal Letters editors appreciate realism over hype.
Mistake #3: Ignoring the Competition
Before you submit, check recent issues. If three similar papers have been published in the last six months, your chances of acceptance drop significantly. That doesn’t mean you shouldn’t try — but you need to be ready to explain why your work is different.
Mistake #4: Treating It Like a Dumping Ground
Some researchers treat ACS Medicinal Letters as a fallback option — “We couldn’t get into J. Med. Chem.Because of that, , so let’s try this. ” That attitude is palpable in the writing, and it shows. Editors can smell desperation from a mile away.
Practical Tips: What Actually Works
Here’s what has worked for me and my colleagues:
Tip #1: Target the Right Stage of Discovery
ACS Medicinal Letters loves early-stage discoveries. Great. Even better. Found a new scaffold with promising activity? Developed a clever synthetic route? But if your paper is mostly about scaling up a known compound, this might not be the right venue.
Tip #2: Lead with the Novelty
Start your abstract with what’s new. Also, not what’s known. What’s new in your work? Not what’s been done before. That’s what will grab attention.
Tip #3: Make Your Figures Tell a Story
Visual abstracts and graphical abstracts aren’t just decoration — they’re your paper’s first impression. Think about it: make them count. If someone scrolls past your paper on Twitter, your figure is what will stop them.
Tip #4: Engage with the Community
ACS Medicinal Letters has an active social media presence. Tag the journal. If your paper gets accepted, share it. Engage with other researchers who cite your work. It’s free marketing for your science.
Tip #5: Don’t Chase Citations
I know it’s tempting to pad your reference list with high-impact papers hoping to boost your own visibility. Think about it: don’t. Cite what’s relevant. Cite what’s honest. The scientific community notices.
FAQ
What is the current impact factor of ACS Medicinal Chemistry Letters?
As of 2023, the impact factor is approximately 5.That said, 7, placing it in the top 20% of chemistry journals. This has been relatively stable over the past few years, with gradual upward trends.
How long does peer review take?
The average time from submission to first decision is about 4–6
The average time from submission to first decision is about 4–6 weeks, though the subsequent revision cycle can stretch the overall timeline by several additional weeks, depending on how extensive the reviewers’ comments are.
When the initial decision arrives, the reviewer reports will typically fall into three categories: major concerns, minor suggestions, and optional recommendations. “Minor” items are generally stylistic or editorial in nature — perhaps a missing reference, a typo, or a request to clarify a figure caption. A “major” comment usually signals that the manuscript cannot be accepted in its current form and that substantial re‑working is required — often involving new experimental data, a revised mechanistic discussion, or a clearer articulation of novelty. Addressing these points promptly and courteously not only speeds the process but also demonstrates professionalism to the editorial team. Less friction, more output.
Responding to reviewer feedback is an art as much as a science. Which means begin each comment with a concise statement of acknowledgment (“We thank the reviewer for pointing out…”) before presenting the revision. Attach line‑by‑line responses when possible; this makes it easy for the editor to verify that every concern has been addressed. If a reviewer’s suggestion would fundamentally alter the scope of the work, it is acceptable — and often advisable — to request a brief discussion with the editor before investing extensive effort.
Beyond the mechanics of revision, there are a few strategic considerations that can improve the odds of a favorable outcome. First, be transparent about the stage of the project when you submit. Think about it: if the data are still preliminary, disclose that fact in the cover letter; editors appreciate honesty and are more likely to view the manuscript as a genuine contribution rather than a finished product that may later require retraction. So second, keep the manuscript tightly focused on the central question. Now, overly broad statements or tangential experiments dilute the signal and can lead reviewers to question the paper’s relevance. Finally, use the revision stage to sharpen the narrative: re‑order paragraphs for logical flow, tighten the language, and check that every claim is directly supported by the presented data.
Boiling it down, success in publishing in ACS Medicinal Letters hinges on a blend of rigor, clarity, and strategic communication. By presenting work that is genuinely novel, framing the story with a compelling visual abstract, and engaging the journal’s community both before and after acceptance, authors can transform a competitive submission into a valued addition to the journal’s portfolio. The editorial team rewards concise, well‑structured reports that respect the journal’s scope and audience, so a disciplined approach — grounded in realistic expectations and thoughtful response to peer review — will ultimately lead to a rewarding publication experience.
